0001104659-18-000924.txt : 20180105
0001104659-18-000924.hdr.sgml : 20180105
20180105130923
ACCESSION NUMBER: 0001104659-18-000924
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180103
FILED AS OF DATE: 20180105
DATE AS OF CHANGE: 20180105
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SAPIRSTEIN JAMES
CENTRAL INDEX KEY: 0001559509
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36856
FILM NUMBER: 18512816
MAIL ADDRESS:
STREET 1: 1517 SAN JACINTO
CITY: HOUSTON
STATE: TX
ZIP: 77002
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ContraVir Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001583771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 462783806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 399 THORNALL STREET
STREET 2: FIRST FLOOR
CITY: EDISON
STATE: NJ
ZIP: 08837
BUSINESS PHONE: 732-902-4000
MAIL ADDRESS:
STREET 1: 399 THORNALL STREET
STREET 2: FIRST FLOOR
CITY: EDISON
STATE: NJ
ZIP: 08837
4
1
a4.xml
4
X0306
4
2018-01-03
0
0001583771
ContraVir Pharmaceuticals, Inc.
CTRV
0001559509
SAPIRSTEIN JAMES
C/O CONTRAVIR PHARMACEUTICALS, INC.
399 THORNALL STREET, FIRST FLOOR
EDISON
NJ
08837
1
1
0
0
Chief Executive Officer
Common Stock
2018-01-03
4
A
0
322092
0
A
492819
D
The reported item represents an award of restricted stock pursuant to the Company's 2013 Equity Incentive Plan. All of the shares vested upon grant. Such shares were issued in lieu of a cash bonus to the reporting person.
/s/ James Sapirstein
2018-01-05